Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Automatic assignment of GO terms using logical inference, based on on inter-ontology links
Combined Automated Annotation using Multiple IEA Methods
AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis.
A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).
Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7.
The human apoptosis-inducing protein AMID is an oxidoreductase with a modified flavin cofactor and DNA binding activity.
Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.
FSP1 is a glutathione-independent ferroptosis suppressor.
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
A reference map of the human binary protein interactome.
A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase.
FSP1 oxidizes NADPH to suppress ferroptosis.
Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.
Structural insight into 6-OH-FAD-dependent activation of hFSP1 for ferroptosis suppression.
ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1.
RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis.
-
RNF126 acts as an anti-ferroptotic gene by interacting with FSP1 and ubiquitinating FSP1 at the 4KR-2 sites
"RNF126 acts as an anti-ferroptotic gene by interacting with ferroptosis suppressor protein 1 (FSP1, also known as AIFM2) and ubiquitinating FSP1 at the 4KR-2 sites"
-
RNF126 deletion reduces plasma membrane localization of FSP1 and increases the CoQ/CoQH2 ratio
"the deletion of RNF126 reduces the subcellular localization of FSP1 in the plasma membrane, resulting in an increase in the CoQ/CoQH2 ratio"
-
The RNF126-FSP1-CoQ10 pathway suppresses phospholipid peroxidation and ferroptosis in vivo and in vitro
"The RNF126-FSP1-CoQ10 pathway plays a pivotal role in suppressing phospholipid peroxidation and ferroptosis both in vivo and in vitro"
Temsirolimus inhibits FSP1 enzyme activity to induce ferroptosis and restrain liver cancer progression.
-
Temsirolimus sensitizes liver cancer cells to ferroptosis by directly binding to and inhibiting FSP1 enzyme activity
"temsirolimus sensitized liver cancer cells to ferroptosis by directly binding to and inhibiting ferroptosis suppressor protein 1 (FSP1) enzyme"
-
Temsirolimus-induced ferroptosis is primarily attributed to FSP1 inhibition rather than mTOR activity
"while temsirolimus is recognized as a potent mammalian target of rapamycin (mTOR) inhibitor, its ferroptosis-inducing effect is primarily attributed to the inhibition of FSP1 rather than mTOR activity"
-
The combination of temsirolimus and RSL3 suppresses liver tumor progression and is associated with increased lipid peroxidation and ferroptosis
"the combination of temsirolimus and RSL3 effectively suppressed liver tumor progression. This tumoricidal effect was associated with increased lipid peroxidation and induction of ferroptosis"
TP53 stimulates AIFM2 gene expression
Deep research on AIFM2/FSP1 function
Comprehensive deep research on AIFM2/FSP1 including structural insights, regulatory mechanisms, and therapeutic implications
-
FSP1 forms a functional homodimer with a unique 25-degree rotation of the FAD isoalloxazine ring; the C-terminal domain mediates dimerization essential for catalytic activity
"The carboxy-terminal domain mediates functional dimerization of FSP1, forming a homodimer that is required for the assembly of FAD- and ubiquinone-binding pockets and for catalytic activity [lv-2023-structural-insights-abstract]. A unique feature of FSP1 structure is the ~25-degree rotation of the FAD isoalloxazine ring compared to all other known FAD-dependent oxidoreductases [lv-2023-structural-insights-abstract]."
-
FSP1 generates 6-hydroxy-FAD which is both an active cofactor and an anti-ferroptotic compound
"This 6-hydroxy-FAD was identified as both an active cofactor of FSP1 and a potent anti-ferroptotic compound in its own right, adding another layer to FSP1's ferroptosis-suppressing mechanisms [lv-2023-structural-insights-abstract]."
-
FSP1 promotes ESCRT-III-dependent membrane repair by recruiting CHMP5 and CHMP6, independent of its enzymatic activity
"FSP1 has been shown to potentiate the recruitment of ESCRT-III subunits CHMP5 and CHMP6 to the plasma membrane following ferroptosis-inducing stress. This pathway operates independently of CoQ10, suggesting that FSP1 has functions beyond its enzymatic activity."
-
FSP1 expression is regulated by the KEAP1-NRF2 pathway; two AREs in the FSP1 promoter bind NRF2
"FSP1 expression is regulated at the transcriptional level by several pathways, most notably the KEAP1-NRF2 antioxidant response pathway. Two antioxidant response elements (AREs), which are canonical NRF2 binding motifs, have been identified in the FSP1 promoter region, and ChIP-qPCR assays confirmed increased NRF2 binding to these AREs upon KEAP1 knockout."
-
KEAP1 mutations in NSCLC lead to elevated FSP1 expression and ferroptosis/radiation resistance
"Consequently, KEAP1 mutations, which are common in non-small cell lung cancer (NSCLC), lead to constitutive NRF2 activation and elevated FSP1 expression, contributing to ferroptosis and radiation resistance [koppula-2022-coq-fsp1-abstract]."
-
icFSP1 (3-phenylquinazolinone) induces FSP1 phase separation and condensate formation, displacing it from membranes
"icFSP1 promotes FSP1 phase separation and condensate formation, displacing FSP1 from membranes and thereby preventing its anti-ferroptotic function [nakamura-2023-phase-separation-abstract]."
-
FSP1 also localizes to lipid droplet periphery where it prevents neutral lipid peroxidation
"Beyond the plasma membrane, FSP1 also localizes to the periphery of lipid droplets (LDs) [nakamura-2023-phase-separation-abstract]. Recent work has revealed that LD-localized FSP1 plays a critical role in preventing neutral lipid peroxidation."
-
iFSP1 is human-specific; F360 is essential for binding (differs from murine FSP1)
"Notably, iFSP1 is human-specific and does not effectively inhibit murine FSP1 due to species differences in an aromatic pocket, with F360 of human FSP1 being essential for iFSP1 binding [dasilva-2023-ifsp1-inhibition-abstract]."
Phase separation of FSP1 promotes ferroptosis
-
icFSP1 promotes FSP1 phase separation and condensate formation, displacing FSP1 from membranes
"We show that icFSP1, unlike iFSP1, the first described on-target FSP1 inhibitor5, does not competitively inhibit FSP1 enzyme activity, but instead triggers subcellular relocalization of FSP1 from the membrane and FSP1 condensation before ferroptosis induction, in synergism with GPX4 inhibition"
-
This mechanism requires N-terminal myristoylation and intrinsically disordered regions
"N-terminal myristoylation, distinct amino acid residues and intrinsically disordered, low-complexity regions in FSP1 were identified to be essential for FSP1-dependent phase separation in cells and in vitro"
-
icFSP1 impairs tumor growth in vivo and induces FSP1 condensates within tumors
"icFSP1 impairs tumour growth and induces FSP1 condensates in tumours in vivo"
Structural insights into FSP1 catalysis and ferroptosis inhibition
-
Crystal structures of Gallus gallus FSP1 at 2.0A (substrate-free) and 2.6A (ubiquinone-bound)
"We report the crystal structures of cFSP1 (residues 12–373, hereafter named cFSP1ΔN) in its substrate-free and ubiquinone (CoQ1)-bound forms at 2.0 and 2.6 Å resolution"
-
FSP1 contains FAD-binding domain, NAD(P)H-binding domain, and C-terminal dimerization domain
"The structures reveal a FAD-binding domain and a NAD(P)H-binding domain, both of which are shared with AIF and NADH oxidoreductases4-9, and a characteristic carboxy-terminal domain as well"
-
Unique 25-degree rotation of FAD isoalloxazine ring compared to other FAD-dependent oxidoreductases
"the isoalloxazine ring of the FAD in cFSP1 rotates ~ 25 degrees compared with that in all known structures of other FAD-dependent oxidoreductases"
-
6-hydroxy-FAD identified as both active cofactor and anti-ferroptotic compound
"identify that FSP1 can catalyze the production of H2O2 and the conversion of FAD to 6-hydroxy-FAD in the presence of oxygen and NAD(P)H in vitro, and 6-hydroxy-FAD directly inhibits ferroptosis in cells"
A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers
-
FSP1 expression is elevated in KEAP1-mutant lung cancers
"KEAP1 mutation or deficiency in lung cancer cells upregulates FSP1 expression through NRF2"
-
CoQ-FSP1 axis contributes to ferroptosis and radiation resistance
"the ubiquinone (CoQ)-FSP1 axis mediates ferroptosis- and radiation- resistance in KEAP1 deficient lung cancer cells"
-
KEAP1 mutations lead to NRF2 activation and FSP1 upregulation
"In this study, we identify ferroptosis suppressor protein 1 (FSP1, also known as AIFM2) as a transcriptional target of nuclear factor erythroid 2-related factor 2 (NRF2) and reveal that the ubiquinone (CoQ)-FSP1 axis mediates ferroptosis- and radiation- resistance in KEAP1 deficient lung cancer cells"
FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers
-
Two antioxidant response elements (AREs) identified in FSP1 promoter
"two antioxidant response elements (AREs) which are well-established NRF2 binding motif were found in FSP1 gene promoter regions"
-
NRF2 directly binds FSP1 promoter confirmed by ChIP-qPCR
"ChIP-qPCR assay was performed to verify the increased binding of NRF2 to the AREs of FSP1 upon KEAP1 knockout"
-
NRF2 activation upregulates FSP1 expression
"suggesting the indispensable role of NRF2 in the regulation of FSP1 expression and ferroptosis sensitivity"
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules
-
iFSP1 shows species-specific inhibition on the human isoform
"explore the species-specific inhibition of iFSP1 on the human isoform to gain insights into its mechanism of action"
-
Species-specific aromatic architecture is essential for target engagement
"establish a critical contribution of a species-specific aromatic architecture that is essential for target engagement"
-
Caution is warranted when using iFSP1 in murine models
"pose a cautionary notice for using iFSP1 in animal models, specifically murine models"